The Critical Role of Fas-Fas Ligand Interaction in Donor-Specific Transfusion-Induced Tolerance to H-Y Antigen

Background. Donor-specific transfusion (DST) has been clinically used to enhance the survival of transplanted organs, and it has been shown in mice to induce tolerance to male (H-Y) antigen (Ag). Although the biologic mechanisms that initiate and maintain DST-induced tolerance involve clonal deletion, induction of anergy, and generation of regulatory cells, the molecules essential to tolerance induction are still unclear. In this study, we investigated the role of Fas-FasL interaction in DST-induced tolerance to H-Y Ag. Methods. C57BL/6 (B6) or B6-Faslpr (lpr) female mice were intravenously injected with B6, lpr, or B6-FasLgld (gld) male spleen cells (SC). B6 male skin grafts, mixed lymphocyte reaction (MLR) assay, and cytotoxicity assay (CTL) were performed 7 days after DST. In some experiments, purified B-cells were used as transfused cells. Results. B6 female mice treated with B6 male SC permanently accepted B6 male skins, whereas untreated B6 or lpr female mice rejected B6 male skins. On the other hand, B6 female mice treated with gld male SC acceleratingly rejected male skin, as did lpr female mice treated with B6 or gld male SC. The recipient mice in the experimental groups, in which DST resulted in the accelerated rejection of the skin grafts, had strong allo-responses to H-Y Ag in MLR and CTL. Further, B6 female mice treated with gld male B-cells acceleratingly rejected male skins, whereas B6 female mice treated with B6 or lpr male B-cells from mice accepted male skins. Conclusions. These findings suggest that the interaction between FasL upon infused SC, especially upon B-cells and Fas in a recipient, is essential in DST-induced tolerance to H-Y Ag.

[1]  Li Zhang,et al.  The Immune Regulatory Function of Lymphoproliferative Double Negative T Cells In Vitro and In Vivo , 2002, The Journal of experimental medicine.

[2]  M. Sykes,et al.  Mixed chimerism and transplant tolerance. , 2001, Immunity.

[3]  H. Waldmann,et al.  Regulating the immune response to transplants. a role for CD4+ regulatory cells? , 2001, Immunity.

[4]  K. Sugimachi,et al.  Cyclophosphamide-induced tolerance in rat orthotopic liver transplantation. , 2001, Transplantation.

[5]  W. Weimar,et al.  Immunologic monitoring of the beneficial effect of one HLA-DR-shared blood transfusion in heart transplant patients. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  S. Okano,et al.  Induction of Permanent Mixed Chimerism and Skin Allograft Tolerance Across Fully MHC-Mismatched Barriers by the Additional Myelosuppressive Treatments in Mice Primed with Allogeneic Spleen Cells Followed by Cyclophosphamide1 , 2000, The Journal of Immunology.

[7]  Li Zhang,et al.  Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression , 2000, Nature Medicine.

[8]  J. Thomas,et al.  Enhanced allograft survival induced by posttransplant donor spleen cell infusion occurs via a mechanism that is distinct from the mechanism of enhancement by donor bone marrow. , 2000, Transplantation.

[9]  R. Zinkernagel,et al.  Donor cell persistence and activation‐induced unresponsiveness of peripheral CD8+ T cells , 2000, European journal of immunology.

[10]  R. Gorczynski,et al.  Dendritic Cells Genetically Engineered to Express Fas Ligand Induce Donor-Specific Hyporesponsiveness and Prolong Allograft Survival1 , 2000, The Journal of Immunology.

[11]  J. Alexander,et al.  Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group. , 1999, Transplantation.

[12]  S. Ménoret,et al.  A Critical Role for Transforming Growth Factor-␤ in Donor Transfusion-induced Allograft Tolerance , 2022 .

[13]  D. Green,et al.  Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells. , 1998, Immunity.

[14]  R. Eisenberg,et al.  Up-regulation of Fas and the costimulatory molecules B7-1 and B7-2 on peripheral lymphocytes in autoimmune B6/gld mice. , 1997, Journal of immunology.

[15]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[16]  G. Freeman,et al.  Coexpression of B7-1 and antigen blocks tolerance induction to antigen presented by resting B cells. , 1996, Journal of immunology.

[17]  D. Green,et al.  CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. , 1996, Immunity.

[18]  J. Tschopp,et al.  Activated B cells express functional Fas ligand , 1996, European journal of immunology.

[19]  K. Shortman,et al.  A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand- induced apoptosis , 1996, The Journal of experimental medicine.

[20]  P. Kourilsky,et al.  Graft-infiltrating T helper cells, CD45RC phenotype, and Th1/Th2-related cytokines in donor-specific transfusion-induced tolerance in adult rats. , 1995, Transplantation.

[21]  P. Krammer,et al.  Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) , 1995, Nature.

[22]  A. Abbas,et al.  The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. , 1994, Immunity.

[23]  N. Jenkins,et al.  Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand , 1994, Cell.

[24]  K. Gilbert,et al.  Tolerogenicity of resting and activated B cells , 1994, The Journal of experimental medicine.

[25]  P. Matzinger,et al.  B cells turn off virgin but not memory T cells. , 1992, Science.

[26]  W. Fung-Leung,et al.  Peripheral deletion of mature CD8+ antigen-specific T cells after in vivo exposure to male antigen. , 1992, Journal of immunology.

[27]  N. Copeland,et al.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.

[28]  L. Johnson Properties of intravenously infused donor cells that prolong the survival of H-Y-disparate skin grafts. , 1988, Transplantation.

[29]  P. Pereira,et al.  T Cell‐Dependent B Cell Activation , 1984, Immunological reviews.

[30]  L. Yang,et al.  Mechanisms of long-term donor-specific allograft survival induced by pretransplant infusion of lymphocytes. , 1998, Blood.